Biosensia: US medical diagnostics company Kypha acquires Biosensia, an Irish diagnostics platform

Niamh O'Luanaigh, Chief Operating Officer, Biosensia. Photo: Nick Bradshaw, Fotonic. Biosensia has been funded by Atlantic Bridge, Seroba Life Sciences, ACT Venture Capital, Street Capital and others previously Kypha, a US medical diagnostics company, developing specialised biomarker testing solutions for precision monitoring of immune status and inflammation, has acquired Biosensia, an Irish diagnostics platform and... Read more »The post US medical diagnostics company Kypha acquires Biosensia, an Irish diagnostics platform appeared first on Business & Finance.